http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1142582-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27155ed29f9b0bfa281f4b21b26d709a
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-06
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-24
filingDate 2000-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9bdbf962df370817fa5e23906c96118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13f45580cd9773c85034e9161839e868
publicationDate 2001-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1142582-A1
titleOfInvention Use of FSH for treating infertility
abstract The present invention relates to the use of FSH and/or a biologically-active analoguenthereof in the production of a medicament for the treatment of infertility in women.nThe medicament is for administration at an initial dose in the range of from 100 to 600nIU followed by a second dose at least 3 days later in the stimulation phase. In onenembodiment, the medicament is for administration a dose in the range of from 300 ton600 IU on every third day of the first 6 days of the stimulation phase. In anothernembodiment, the initial dose is in the range of from 100 to 500 IU, with the secondndose being administered between three and six, preferably four, days after the initialndose.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03055991-A1
priorityDate 2000-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4725579-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408786858
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128960895
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID8010
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399646
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID8010
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421267
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID657180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534840
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID657181
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421266
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491336
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323226
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1548953
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399323
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1548955
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2800
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18609376
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395420
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399016
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396304
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6128
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6013
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6279
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57366955
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396305
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134688829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396558
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412044
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5757
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127394830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412045
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5994
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581161

Total number of triples: 51.